Expression of type 1 cannabinoid receptor gene in bipolar disorder

Arjmand, 2019, Bipolar disorder and the endocannabinoid system, Acta Neuropsychiatr., 31, 193, 10.1017/neu.2019.21 Ashton, 2011, Endocannabinoid system dysfunction in mood and related disorders, Acta Psychiatr. Scand., 10.1111/j.1600-0447.2011.01687.x Ashton, 2005, Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential, J. Psychopharmacol., 19, 293, 10.1177/0269881105051541 Baldessarini, 2013 Belvederi Murri, 2016, The HPA axis in bipolar disorder: systematic review and meta-analysis, Psychoneuroendocrinology, 10.1016/j.psyneuen.2015.10.014 Bhattacharyya, 2021, Exo- and endo-cannabinoids in depressive and suicidal behaviors, Front. Psychiatr. Bürkner, 2017, Brms}: an {R} package for {bayesian} multilevel models using {stan, J. Stat. Software, 80, 1, 10.18637/jss.v080.i01 Choi, 2012, Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear, J. Psychiatr. Res., 46, 882, 10.1016/j.jpsychires.2012.03.021 D'Addario, 2017, A preliminary study of endocannabinoid system regulation in psychosis: distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia, Schizophr. Res., 10.1016/j.schres.2017.01.022 D'Addario, 2018, Regulation of gene transcription in bipolar disorders: role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor, Prog. Neuro Psychopharmacol. Biol. Psychiatr., 82, 314, 10.1016/j.pnpbp.2017.08.011 de Torrenté, 2020, The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data, BMC Bioinf., 21, 1, 10.1186/s12859-020-03892-w Delignette-Muller, 2014 Desjardins, 2010, NanoDrop microvolume quantitation of nucleic acids, JoVE, 10.3791/2565-v Di Marzo, 2009, The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation, Pharmacol. Res., 10.1016/j.phrs.2009.02.010 Escelsior, 2021, Cannabinoid use and self-injurious behaviours: a systematic review and meta-analysis, J. Affect. Disord., 278, 85, 10.1016/j.jad.2020.09.020 Fanelli, 2017, Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women, Mol. Metabol., 6, 406, 10.1016/j.molmet.2017.03.005 Fanelli, 2018, Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism, Mol. Metabol., 14, 82, 10.1016/j.molmet.2018.06.002 Garani, 2021, Endocannabinoid system in psychotic and mood disorders, a review of human studies, Prog. Neuro Psychopharmacol. Biol. Psychiatr., 106, 10.1016/j.pnpbp.2020.110096 Hill, 2018, Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder, Neuropsychopharmacology, 43, 80, 10.1038/npp.2017.162 Hungund, 2004, Upregulation of CB 1 receptors and agonist-stimulated [ 35 S]GTPcS binding in the prefrontal cortex of depressed suicide victims, Mol. Psychiatr., 9, 184, 10.1038/sj.mp.4001376 Kay, 2021 Koethe, 2007, Expression of CB1cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression, J. Neural. Transm., 10.1007/s00702-007-0660-5 Koethe, 2018, Familial abnormalities of endocannabinoid signaling in schizophrenia, World J. Biol. Psychiatr. Ledderose, 2011, Selection of reliable reference genes for quantitative real-time PCR in human T cells and neutrophils, BMC Res. Notes, 4 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262 Lowe, 2021, The endocannabinoid system: a potential target for the treatment of various diseases, Int. J. Mol. Sci., 22, 10.3390/ijms22179472 Lutz, 2015, The endocannabinoid system in guarding against fear, anxiety and stress, Nat. Rev. Neurosci., 10.1038/nrn4036 Magioncalda, 2018, White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: combined DTI and immunological investigation in the different phases of bipolar disorder, Brain Behav. Immun., 73, 192, 10.1016/j.bbi.2018.04.017 Markopoulou, 2021, Comparison of hypothalamo-pituitary-adrenal function in treatment resistant unipolar and bipolar depression, Transl. Psychiatry, 11, 244, 10.1038/s41398-021-01343-5 Martino, 2016, Contrasting variability patterns in the default mode and sensorimotor networks balance in bipolar depression and mania, Proc. Natl. Acad. Sci. U. S. A, 113, 10.1073/pnas.1517558113 McElreath, 2020 McIntyre, 2020, Bipolar disorders, Lancet, 396, 1841, 10.1016/S0140-6736(20)31544-0 Micale, 2018, Endocannabinoid system, stress and HPA axis, Eur. J. Pharmacol., 834, 230, 10.1016/j.ejphar.2018.07.039 Minocci, 2011, Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor, J. Affect. Disord., 10.1016/j.jad.2011.05.023 Monteleone, 2010, Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression, Pharmacol. Res., 10.1016/j.phrs.2010.01.002 Morena, 2015, Neurobiological interactions between stress and the endocannabinoid system, Neuropsychopharmacology, 411 41, 80 Munkholm, 2012, State-related alterations of gene expression in bipolar disorder: a systematic review, Bipolar Disord., 14, 684, 10.1111/bdi.12005 Patel, 2004, Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis, Endocrinology, 145, 5431, 10.1210/en.2004-0638 Pisanu, 2013, No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample, Psychiatr. Res., 10.1016/j.psychres.2013.09.025 Rosenbaum, 2010 Sher, 2019, Endogenous cannabinoids and suicide, Aust. N. Z. J. Psychiatr., 53, 263, 10.1177/0004867418817373 Sigitova, 2017, Biological hypotheses and biomarkers of bipolar disorder, Psychiatr. Clin. Neurosci., 71, 77, 10.1111/pcn.12476 Tsai, 2001, Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders, Am. J. Med. Genet. Neuropsychiatr. Genet., 10.1002/ajmg.1259 Vehtari, 2017, Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC, Stat. Comput., 27, 1413, 10.1007/s11222-016-9696-4 Volkow, 2017, Don't worry, Be happy: endocannabinoids and cannabis at the intersection of stress and reward, Annu. Rev. Pharmacol. Toxicol., 10.1146/annurev-pharmtox-010716-104615 Williams, 2019, A Bayesian non-linear mixed-effects location scale model for learning, Behav. Res. Methods, 51, 1968, 10.3758/s13428-019-01255-9 Witt, 2014, Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder, Transl. Psychiatry, 4, 10.1038/tp.2014.71 Zou, 2018, Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system, Int. J. Mol. Sci., 19, 10.3390/ijms19030833